Conn. gets piece of $500 million generic drug settlement from India

Connecticut Attorney General George Jepsen said Tuesday the state will get about $1.5 million from Ranbaxy, the India-based generic drug maker, who settled allegations this week that it was selling generics that were less than full strength or less than pure.

Ranbaxy agreed to settle the charges after a whistleblower made allegations about its drugs in court. The feds and states got involved because, ultimately because Medicaid, like private insurance policies, pushes patients to use cheaper generics when available. In all, the Indian pharmaceutical made 26 generic type of drugs between 2003 and 2010.

Ranbaxy agreed to pay fines and restitution to Medicaid programs, while not admitting it did anything wrong.


Rob Varnon

One Response

  1. JimmyP333 says:

    The state gets a 1.5 million dollar settlement for inferior and tainted generic drugs made by a foreign company. What about the people here in Ct. who took these medicines filled by all the CVS’s, Walgreens, and others? Are they going to be left out in the cold? The citizens have very little say in where their medicines are procured. These chain pharmacies, insurance companies and pharmaceutical corporations, will do anything to maximize their profits instead of putting the health and well-being of the people first.
    I read about this Ranbaxy outfit several months ago and stopped CVS from giving my mom their generic brand of Lipitor. It cost us more getting the brand name and now I know it was worth it. But where is the outrage of the people not only in Ct but the entire country? Where’s the investigations? If you don’t believe that this is only the tip of the iceberg, then there’s a bridge in Brooklyn I’d like to sell you.